Literature DB >> 8000749

How does neurophysiological assessment influence the management and outcome of patients with carpal tunnel syndrome?

S J Boniface1, I Morris, A Macleod.   

Abstract

The objective of this study was to determine how neurophysiological assessment influenced the management and outcome of 100 consecutive patients referred to a department of clinical neurophysiology in a district general hospital with a provisional clinical diagnosis of carpal tunnel syndrome. Nerve conduction studies excluded the diagnosis in 36 patients who may have otherwise received inappropriate treatment. The decision whether to perform a carpal tunnel decompression was greatly influenced by a positive study. Symptoms subsequently resolved in 72-86% of patients treated on this basis, depending on the mode of treatment and the nerve conduction study findings, with similar outcomes for surgical and conservative measures. The clinical and estimated resource implications of this diagnostic service were found to be substantial.

Entities:  

Mesh:

Year:  1994        PMID: 8000749     DOI: 10.1093/rheumatology/33.12.1169

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

1.  Italian multicentre study of carpal tunnel syndrome: study design. Italian CTS Study Group.

Authors:  L Padua; R Padua; M LoMonaco; E Romanini; P Tonali
Journal:  Ital J Neurol Sci       Date:  1998-10

2.  Utilization of Preoperative Electrodiagnostic Studies for Carpal Tunnel Syndrome: An Analysis of National Practice Patterns.

Authors:  Erika D Sears; Peter R Swiatek; Hechuan Hou; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2016-04-09       Impact factor: 2.230

Review 3.  Diagnosis of carpal tunnel syndrome.

Authors:  Michael Warren Keith; Victoria Masear; Kevin Chung; Kent Maupin; Michael Andary; Peter C Amadio; Richard W Barth; William C Watters; Michael J Goldberg; Robert H Haralson; Charles M Turkelson; Janet L Wies
Journal:  J Am Acad Orthop Surg       Date:  2009-06       Impact factor: 3.020

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.